Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Moleculin Announces FDA Filing for Orphan Drug Designation for Glioblastoma Drug

americanpharmaceuticalreviewDecember 10, 2018

Tag: Moleculin , FDA , Orphan Drug , Glioblastoma Drug

PharmaSources Customer Service